One-Year Effectiveness Study of Intravitreously Administered Conbercept<sup>®</sup> Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis.

Diabetes Ther · 2020 · PMC7192996 · PMID 32236812

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Increased injection frequency demonstrates a significant trend with improved outcomes at 12 months.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.